AltMountain

Life Sciences Innovation Fund II, L.P.

New York, NY · CIK 1870508
Status: no Form D since Jul 2023. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Life Sciences Innovation Fund II, L.P. is a private investment fund based in New York, New York. According to its most recent Form D, filed Jul 20, 2023, it has sold $10,808,755 of interests to 38 investors since its first sale in May 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include David Greenhouse; Life Sciences Innovation GP LLC; David Sable.

Total raised
$10,808,755Cumulative sales reported on Form D
Investors
38
First sale
May 17, 2021
Minimum investment
None set
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(b)No general advertising
Key people and entities
David Greenhouse; Life Sciences Innovation GP LLC; David Sable
Latest Form D
Jul 20, 2023

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​​⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Jul 20, 2023Form D/A (amendment)$10,808,75538SEC.gov ↗
Jul 16, 2021Form D$10,808,75538SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 16, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Life Sciences Innovation Fund II, L.P.

What is the minimum investment for Life Sciences Innovation Fund II, L.P.?

Life Sciences Innovation Fund II, L.P.'s latest Form D, filed Jul 20, 2023, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Life Sciences Innovation Fund II, L.P.?

Life Sciences Innovation Fund II, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.

How much has Life Sciences Innovation Fund II, L.P. raised?

Life Sciences Innovation Fund II, L.P. reports $10,808,755 sold from 38 investors on its Form D filed Jul 20, 2023. This is cumulative sales since the offering began, not current assets or performance.

Where is Life Sciences Innovation Fund II, L.P. based?

Life Sciences Innovation Fund II, L.P. is based in New York, New York.

When did Life Sciences Innovation Fund II, L.P. launch?

Life Sciences Innovation Fund II, L.P. reports its first sale in May 2021.

Size compared with every private investment fund

Raised more than 48% of the 2,862 private investment funds based in New York, and more than 43% of all 10,363 that report sales.

Other funds with the same team

More private investment funds in New York

Similar-size private investment funds in New York

All private investment funds in New York